Plant protein specialist Burcon has announced the first successful commercial production of its Peazazz C pea protein ingredient at its Galesburg facility in Illinois, US.

The company is a global provider of plant-based ingredients, with an extensive patent portfolio covering novel proteins derived from pea, canola, soya, hemp, sunflower and other plant sources.

Its Peazazz protein is made using the company’s proprietary technology that transforms yellow field peas into high-purity protein islolates, offering a neutral flavour, light colour and versatile functionality. Product applications include beverages, dairy alternatives, baked goods, nutrition bars and more.

With commercial production of Peazazz now underway and ramping throughout the second half of the year, Burcon said it is actively progressing customer supply agreements that will support long-term recurring revenue.

The Galesburg facility provides capacity to scale production, positioning Burcon to executive its growth strategy and expand market penetration.

Kip Underwood, CEO of Burcon, said: “The successful start-up of our Galesburg facility marks a key operational milestone in Burcon’s commercial scale-up”.

“In less than 90 days since commissioning, our team has brought next-generation protein production online, enabling us to meet accelerating customer demand and unlock scalable revenue opportunities.”

Burcon confirmed it is on track to achieve key operational and financial milestones through 2025 into 2026, anticipating $1-3 million in revenue for calendar year 2025 and over $10 million in revenue for calendar year 2026.